AGP Picks
View all

Middle East News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Network.

Press releases published on April 21, 2026

Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026
ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026
Best Startup Story Expands Editorial Submission Opportunities for UAE Entrepreneurs
YRC Announces Specialized Consulting Framework to Modernize Independent Grocery and Supermarket Operations Globally
Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
Oculis Publishes Invitation to the Annual General Meeting
Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
The World Alliance Releases 2026 Report on Artificial Intelligence in Financial Services
Architecture in Uncertain Times: Iterative Visualization Replaces Final Renders
A New Book That Challenges Intelligence, Humanity, and the Unknown
Tamatem Acquires Playable Factory to Expand into Ad Tech and Accelerate Its AI-First Gaming Platform
طماطم تستحوذ على بلايبل فاكتوري التركية لدخول مجال الإعلانات التفاعلية وتسريع بناء منصة ألعاب قائمة على الذكاء الاصطناعي
FMUSER Releases Video Guide Detailing Hotel IPTV Solution Pricing and Setup
FMUSER Releases Multi-Language Video Guide for Setting Up Hotel IPTV Systems
BurjX Expands Stablecoin Infrastructure Under ADGM Regulation
Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.